Patents by Inventor Shaun Raj Selness

Shaun Raj Selness has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210352891
    Abstract: Provided herein are containerized liquid formulations comprising a plurality of agrochemicals. The formulations comprise a plurality of parallel liquid layers, wherein each layer is disposed within the container such that it is in contact with at least one adjacent layer at an interface. Also provided are methods of preparing, storing, shipping, and using the containerized liquid formulations.
    Type: Application
    Filed: July 29, 2021
    Publication date: November 18, 2021
    Applicant: Monsanto Technology LLC
    Inventors: Ronald Francis Colletti, Shaun Raj Selness, Daniel James Seyer
  • Patent number: 11089776
    Abstract: Provided herein are containerized liquid formulations comprising a plurality of agrochemicals. The formulations comprise a plurality of parallel liquid layers, wherein each layer is disposed within the container such that it is in contact with at least one adjacent layer at an interface. Also provided are methods of preparing, storing, shipping, and using the containerized liquid formulations.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: August 17, 2021
    Assignee: Monsanto Technology LLC
    Inventors: Ronald Francis Colletti, Shaun Raj Selness, Daniel James Seyer
  • Patent number: 11076603
    Abstract: The present disclosure provides aqueous inoculant compositions and methods for enhancing the survival and/or stability of microbial spores in an inoculant composition. In some embodiments, aqueous inoculant compositions of the present disclosure comprise microbial spores, one or more dispersants, one or more protectants, one or more aqueous additives and a non-aqueous liquid carrier.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: August 3, 2021
    Assignees: NOVOZYMES BIOAG A/S, MONSANTO TECHNOLOGY LLC.
    Inventors: Dave Greenshields, Kristi Woods, Shaun Raj Selness, Hui Han
  • Publication number: 20210219554
    Abstract: The present disclosure provides aqueous inoculant compositions and methods for enhancing the survival and/or stability of microbial spores in an inoculant composition. In some embodiments, aqueous inoculant compositions of the present disclosure comprise microbial spores, one or more dispersants, one or more protectants, one or more aqueous additives and a non-aqueous liquid carrier.
    Type: Application
    Filed: April 6, 2021
    Publication date: July 22, 2021
    Applicants: NOVOZYMES BIOAG A/S, MONSANTO TECHNOLOGY LLC.
    Inventors: Dave Greenshields, Kristi Woods, Shaun Raj Selness, Hui Han
  • Publication number: 20210002251
    Abstract: Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (BTK). Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the BTK inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
    Type: Application
    Filed: September 18, 2020
    Publication date: January 7, 2021
    Applicant: Pfizer Inc.
    Inventors: John Robert Springer, Balekudru Devadas, Danny James Garland, Margaret Lanahan Grapperhaus, Seungil Han, Susan Landis Hockerman, Robert Owen Hughes, Eddine Saiah, Mark Edward Schnute, Shaun Raj Selness, Daniel Patrick Walker, Zhao-Kui Wan, Li Xing, Christoph Wolfgang Zapf, Michelle Ann Schmidt
  • Patent number: 10874109
    Abstract: The present disclosure provides non-aqueous inoculant compositions and methods for enhancing the survival and/or stability of microbial spores in an inoculant composition. In some embodiments, inoculant compositions of the present disclosure comprise microbial spores, one or more dispersants, one or more protectants and a non-aqueous liquid carrier.
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: December 29, 2020
    Assignees: NOVOZYMES BIOAG A/S, MONSANTO TECHNOLOGY LLC
    Inventors: Dave Greenshields, Vincent Martin, Shaun Raj Selness, Hui Han
  • Patent number: 10856552
    Abstract: The present disclosure provides non-aqueous inoculant compositions and methods for enhancing the survival and/or stability of microbial spores in an inoculant composition. In some embodiments, inoculant compositions of the present disclosure comprise microbial spores, one or more dispersants, one or more protectants and a non-aqueous liquid carrier.
    Type: Grant
    Filed: February 18, 2019
    Date of Patent: December 8, 2020
    Assignees: NOVOZYMES BIOAG A/S, MONSANTO TECHNOLOGY LLC
    Inventors: Dave Greenshields, Vincent Martin, Shaun Raj Selness, Hui Han
  • Patent number: 10815213
    Abstract: Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (BTK). Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the BTK inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: October 27, 2020
    Assignee: Pfizer Inc.
    Inventors: John Robert Springer, Balekudru Devadas, Danny James Garland, Margaret Lanahan Grapperhaus, Seungil Han, Susan Landis Hockerman, Robert Owen Hughes, Eddine Saiah, Mark Edward Schnute, Shaun Raj Selness, Daniel Patrick Walker, Zhao-Kui Wan, Li Xing, Christoph Wolfgang Zapf, Michelle Ann Schmidt
  • Publication number: 20200275648
    Abstract: Provided herein are treated seeds and methods for the preparation of treated seeds comprising a biological agent and a polymeric coating.
    Type: Application
    Filed: September 12, 2018
    Publication date: September 3, 2020
    Applicant: Monsanto Technology LLC
    Inventors: William Abraham, Gulam Ahmed, Shaun Raj Selness
  • Publication number: 20200107548
    Abstract: Provided herein are aqueous suspension concentrate compositions comprising biologically active 3,5-disubstituted-1,2,4-oxadiazoles or salts thereof that are useful, for example, in the control of nematodes.
    Type: Application
    Filed: December 6, 2019
    Publication date: April 9, 2020
    Applicant: Monsanto Technology LLC
    Inventors: Yiwei Ding, Shaun Raj Selness, Urszula J. Slomczynska
  • Patent number: 10499645
    Abstract: Provided herein are aqueous suspension concentrate compositions comprising biologically active 3,5-disubstituted-1,2,4-oxadiazoles or salts thereof that are useful, for example, in the control of nematodes.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: December 10, 2019
    Assignee: MONSANTO TECHNOLOGY, LLC
    Inventors: Yiwei Ding, Shaun Raj Selness, Urszula J. Slomczynska
  • Publication number: 20190202798
    Abstract: Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (BTK). Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the BTK inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases cases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
    Type: Application
    Filed: March 8, 2019
    Publication date: July 4, 2019
    Applicant: Pfizer Inc.
    Inventors: John Robert Springer, Balekudru Devadas, Danny James Garland, Margaret Lanahan Grapperhaus, Seungil Han, Susan Landis Hockerman, Robert Owen Hughes, Eddine Saiah, Mark Edward Schnute, Shaun Raj Selness, Daniel Patrick Walker, Zhao-Kui Wan, Li Xing, Christoph Wolfgang Zapf, Michelle Ann Schmidt
  • Publication number: 20190174767
    Abstract: The present disclosure provides non-aqueous inoculant compositions and methods for enhancing the survival and/or stability of microbial spores in an inoculant composition. In some embodiments, inoculant compositions of the present disclosure comprise microbial spores, one or more dispersants, one or more protectants and a non-aqueous liquid carrier.
    Type: Application
    Filed: February 18, 2019
    Publication date: June 13, 2019
    Applicants: NOVOZYMES BIOAG A/S, MONSANTO TECHNOLOGY LLC
    Inventors: Dave Greenshields, Vincent Martin, Shaun Raj Selness, Hui Han
  • Publication number: 20190174766
    Abstract: The present disclosure provides non-aqueous inoculant compositions and methods for enhancing the survival and/or stability of microbial spores in an inoculant composition. In some embodiments, inoculant compositions of the present disclosure comprise microbial spores, one or more dispersants, one or more protectants and a non-aqueous liquid carrier.
    Type: Application
    Filed: February 14, 2019
    Publication date: June 13, 2019
    Applicants: NOVOZYMES BIOAG A/S, MONSANTO TECHNOLOGY LLC
    Inventors: Dave Greenshields, Vincent Martin, Shaun Raj Selness, Hui Han
  • Patent number: 10266513
    Abstract: Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (BTK). Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the BTK inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseeases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: April 23, 2019
    Assignee: Pfizer Inc.
    Inventors: John Robert Springer, Balekudru Devadas, Danny James Garland, Margaret Lanahan Grapperhaus, Seungil Han, Susan Landis Hockerman, Robert Owen Hughes, Eddine Saiah, Mark Edward Schnute, Shaun Raj Selness, Daniel Patrick Walker, Zhao-Kui Wan, Li Xing, Christoph Wolfgang Zapf, Michelle Ann Schmidt
  • Publication number: 20190090487
    Abstract: Provided herein are aqueous suspension concentrate compositions comprising biologically active 3,5-disubstituted-1,2,4-oxadiazoles or salts thereof that are useful, for example, in the control of nematodes.
    Type: Application
    Filed: September 27, 2018
    Publication date: March 28, 2019
    Applicant: Monsanto Technology LLC
    Inventors: Yiwei Ding, Shaun Raj Selness, Urszula J. Slomczynska
  • Publication number: 20190014786
    Abstract: The present disclosure provides non-aqueous inoculant compositions and methods for enhancing the survival and/or stability of microbial spores in an inoculant composition. In some embodiments, inoculant compositions of the present disclosure comprise microbial spores, one or more dispersants, one or more protectants and a non-aqueous liquid carrier.
    Type: Application
    Filed: December 20, 2016
    Publication date: January 17, 2019
    Applicants: NOVOZYMES BIOAG A/S, MONSANTO TECHNOLOGY LLC
    Inventors: Dave Greenshields, Vincent Martin, Shaun Raj Selness, Hui Han
  • Publication number: 20190014787
    Abstract: The present disclosure provides aqueous inoculant compositions and methods for enhancing the survival and/or stability of microbial spores in an inoculant composition. In some embodiments, aqueous inoculant compositions of the present disclosure comprise microbial spores, one or more dispersants, one or more protectants, one or more aqueous additives and a non-aqueous liquid carrier.
    Type: Application
    Filed: December 20, 2016
    Publication date: January 17, 2019
    Applicants: NOVOZYMES BIOAG A/S, MONSANTO TECHNOLOGY LLC
    Inventors: Dave Greenshields, Kristi Woods, Shaun Raj Selness, Hui Han
  • Patent number: 10117434
    Abstract: Provided herein are aqueous suspension concentrate compositions comprising biologically active 3,5-disubstituted-1,2,4-oxadiazoles or salts thereof that are useful, for example, in the control of nematodes.
    Type: Grant
    Filed: December 4, 2013
    Date of Patent: November 6, 2018
    Assignee: Monsanto Technology LLC
    Inventors: Yiwei Ding, Shaun Raj Selness, Urszula J. Slomczynska
  • Publication number: 20180249705
    Abstract: Provided herein are containerized liquid formulations comprising a plurality of agrochemicals. The formulations comprise a plurality of parallel liquid layers, wherein each layer is disposed within the container such that it is in contact with at least one adjacent layer at an interface. Also provided are methods of preparing, storing, shipping, and using the containerized liquid formulations.
    Type: Application
    Filed: February 28, 2018
    Publication date: September 6, 2018
    Applicant: Monsanto Technology LLC
    Inventors: Ronald Francis Colletti, Shaun Raj Selness, Daniel James Seyer